Find Academic Supervisors

Clinical Associate Professor Keith Ong is affiliated with the University of Sydney’s Northern Clinical School, specifically within the Department of Clinical Ophthalmology & Eye Health. His clinical specialty is Ophthalmology, with a focus on corneal endothelial health, glaucoma surgery outcomes, and cataract surgical techniques. His research addresses critical areas such as postoperative ocular toxicity, intraocular lens calculations, and infection control in eye surgeries. Dr. Ong’s publications (2011–2023) consistently explore topics like corneal endothelial changes post-trabeculectomy, refractive error management post-cataract surgery, and antibiotic prophylaxis strategies. Recent work emphasizes optimizing surgical techniques to reduce complications, such as BAK-induced corneal toxicity and IOL power calculation accuracy in LASIK patients. His work demonstrates a focus on improving surgical safety and precision, with studies evaluating alternative antibiotic delivery methods and laser therapy impacts. No awards or grants are explicitly noted in the provided text, but his contributions to clinical practice and surgical protocols are evident through his publication record.

• Ophthalmology
• Corneal Endothelial Health
• Cataract Surgery Outcomes
• +3 more

Dr. John Males is a Clinical Senior Lecturer at the University of Sydney and Director of Ophthalmology Training at Sydney Eye Hospital. His clinical and research expertise focuses on corneal surgery, cataract surgery, and laser vision correction. He pioneered Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) in Australia and is conducting clinical trials on Collagen Cross-Linking for keratoconus. His research spans corneal transplantation techniques, refractive error management, and ocular surface regeneration. Dr. Males holds roles as a consultant at major hospitals and serves as an examiner for the Royal Australian & New Zealand College of Ophthalmologists. Research interests include corneal biomechanics, surgical innovation for keratoconus, and outcomes analysis of cross-linking therapies. He leads studies on corneal densitometry, dry eye correlations, and long-term efficacy of surgical interventions. His work bridges clinical practice with translational research in regenerative medicine and ocular surface engineering. Publications span over 20 years, emphasizing corneal transplantation advancements, keratoconus management, and surgical complication resolution. His contributions to global consensus guidelines for endothelial keratoplasty highlight leadership in standardizing surgical practices.

• Ophthalmology
• Corneal Surgery
• Laser Vision Correction
• +3 more

Professor Gerard Sutton is an Honorary Professor in the Faculty of Medicine and Health at the University of Sydney, affiliated with the Save Sight Institute and Vision Eye Institute. He specializes in corneal and refractive surgery, combining clinical practice with research in keratoconus, corneal bioengineering, and global eye care. His work includes developing the Australian Corneal Bioengineering Centre and pioneering innovations like the Corneal Biopen for treating corneal defects. Research interests span clinical and laboratory-based studies, focusing on corneal transplantation, bioengineered treatments, and refractive surgery outcomes. Current projects include corneal bioengineering, keratoconus pathogenesis, and SMILE surgery clinical outcomes. He holds memberships in prominent ophthalmology societies like RANZCO and APPO. Awards: 2019 RANZCO John C. Parr Medal Lecture Award 2017 Sydney Research Centre ‘Big Idea’ Innovation Award 2015 XOVA Excellence in International Ophthalmology 2014 Asia Pacific Academy of Ophthalmology Achievement Award Grants & Funding: AU$35M BIENCO consortium (2023) for corneal blindness therapies AU$1.1M Corneal Biopen commercialization (2018) NHMRC Ideas Grant for bioengineered corneal layers (2019) His research group collaborates internationally, with projects addressing corneal transplantation equity, bioink development, and regenerative solutions for ocular surface diseases. Clinical affiliations include Sydney Eye Hospital and the Lions NSW Eye Bank.

• Ophthalmology
• Corneal Diseases
• Keratoconus
• +3 more

Dr. Jingjing You is a Senior Lecturer in Biomedicine and Lead Tutor in Pathogenesis at the University of Sydney's School of Medical Sciences and Save Sight Institute. She leads the Innovative Biomedicine Research Group and holds a Sydney Horizon Fellowship. Affiliated with UNSW's School of Optometry, the NSW Tissue Bank, and iFix Medical Pty Ltd, her work focuses on biomaterials, 3D bioprinting, and regenerative medicine. Her research addresses corneal diseases, collagen-based therapies, and machine learning applications in healthcare. Major grants include $35M from MRFF (2023) and NHMRC funding (2020). Awards include the Global Development Award (2022). She supervises PhD/Master’s students in collagen engineering and ocular bioengineering. International collaborations span institutions in China, Germany, New Zealand, Saudi Arabia, and the U.S., particularly in corneal bioengineering and AI-driven diagnostics. Research interests include advanced manufacturing of biomaterials, collagen applications, and integrating machine learning for disease diagnosis. Current projects explore collagen's role in tissues, bioengineered eye tissues, and machine learning platforms for medical monitoring. Her lab develops transparent bioinks, platelet-based adhesives, and AI models for keratoconus classification. Collaborations with Harvard Medical School and Fudan University highlight her global impact in biomedical innovation. Awards: MRFF Frontier Health 2023 ($35M), NHMRC Idea Grant 2020, NSW Medical Device Fund 2018 Grants: Sydney Horizon Fellowship (biomanufacturing), BIENCO (corneal bioengineering) Clinical Focus: Corneal diseases, regenerative therapies, ocular surface disorders Industry Links: iFix Medical (biomedical devices), Retina Repair International Publications span biomaterials, corneal bioengineering, and AI applications, with recent work in Acta Biomaterialia , Materials Horizons , and Translational Vision Science and Technology .

• Biomaterials
• 3D Bioprinting
• Tissue Engineering
• +5 more

Charles Cranfield is an Associate Professor in the School of Life Sciences at the University of Technology Sydney (UTS). He leads the Membrane Biophysics Group and has held roles such as Director of HDR Programs (2021–present) and Program Director for Biomedical Science degrees. His research focuses on membrane biophysics, ion channels, and biosensor development, with applications in medical diagnostics and disease studies. He has pioneered technologies like the world’s first nonlinear endoscope and lipid-based biosensors for detecting diseases like inflammatory bowel disorder. Cranfield earned his PhD in Biophysics from Swinburne University of Technology and completed postdoctoral work in the UK and Germany, including Marie Curie Fellowships. His academic career includes leadership roles in curriculum design and research administration. Education: BSc (Honours) in Pharmacology (Monash University, 1996), PhD in Biophysics (Swinburne University of Technology, 2002). Key research areas include membrane-ion interactions, lipid-peptide dynamics, and diagnostic device innovation. He collaborates internationally on projects funded by grants exceeding $15M, including roles as team leader and discipline deputy. Awards include Marie Curie Fellowships and recognition for discoveries in biogenic magnetite and ion channel clustering. Leadership: Director of HDR Programs (Science Faculty), Program Director (Medical Science & Advanced Science) Grants: ARC Research Hub for Integrated Device for End-user Analysis at Low-levels (2017–2023) Service: Peer review for journals like Journal of Colloid and Interface Science , member of the Biophysical Society Current lab activities include developing novel biosensors for lipase activity and phospholipase detection. His team investigates mechanisms of antimicrobial resistance and ion transport in biological membranes, with applications in COPD and IBD diagnostics.

• Membrane Biophysics
• Biosensor Development
• Ion Channel Dynamics
• +3 more

Dr. Vincent Daien is a Clinical Professor at the Save Sight Institute, University of Sydney's Faculty of Medicine and Health. His research focuses on ophthalmic conditions including glaucoma, macular degeneration, diabetic retinopathy, and retinal imaging. Key areas of investigation include anti-VEGF therapies, retinal microcirculation, and clinical registry data analysis. He has contributed to over 50 peer-reviewed publications since 2016, with recent work emphasizing real-world evidence for anti-VEGF treatments in age-related macular degeneration and diabetic macular edema. His studies often involve large observational datasets like the Fight Retinal Blindness! Project and Save Sight Registries. Dr. Daien's work bridges clinical practice and research, addressing treatment efficacy, patient outcomes, and healthcare delivery optimization. Notable contributions include evaluations of cyclophotocoagulation for glaucoma, keratoconus risk factors, and quality-of-life impacts of eye diseases. His research collaborations span institutions globally, with a focus on translational studies that inform clinical guidelines and improve patient management strategies.

• Ophthalmology
• Glaucoma
• Macular Degeneration
• +7 more

Professor Chameen Samarawickrama is a clinician-scientist at the University of Sydney (Faculty of Medicine and Health, Department of Clinical Ophthalmology and Eye Health) and the Westmead Institute for Medical Research . He serves as a Consultant Ophthalmologist at Westmead Hospital, specializing in corneal transplantation and complex cataract surgery. BSc(Med), MBBS, PhD, FRANZCO Leader in corneal regeneration and AI-driven clinical audits Research Interests span basic science (novel therapeutics for corneal neovascularization, neuropathic corneal disease) and clinical applications (AI in clinical audits, cataract registry development). His work integrates animal models , clinical trials , and surgical innovation . Recent publications focus on orthokeratology risks , endothelial keratoplasty techniques, and multifocal lens protocols , reflecting his expertise in corneal disease and refractive surgery . Scientific Awards : ABC Top 5 Scientists (2019), NHMRC Investigator Fellow (2020-24) Teaching & Supervision : Unit Co-Ordinator for the Master of Medicine (Ophthalmic Science) at the University of Sydney, with regular training for registrars at Westmead and Liverpool Hospitals. Labs & Teams : Affiliated with the Save Sight Institute and Westmead Institute for Medical Research, focusing on ophthalmology, infection, and immunological conditions.

• Ophthalmology
• Corneal Diseases
• Cataract Surgery
• +5 more

Sally Stephenson is an Associate Professor at Queensland University of Technology in the Faculty of Health, School of Biomedical Sciences, where she leads research focused on cancer biology and receptor tyrosine kinases. Her work bridges basic science with translational applications in oncology, particularly in prostate and breast cancers. Dr. Stephenson earned her PhD and B.Sc (Hons) from the University of Queensland. Her educational background provided the foundation for her current research program investigating molecular mechanisms in cancer progression. Her primary research interests center on the EphB4 receptor tyrosine kinase and its role in epithelial cancers. Dr. Stephenson's laboratory investigates how EphB4 contributes to tumor development through promoting angiogenesis, increasing cancer cell survival, and facilitating invasion and migration. A major focus of her work involves developing monoclonal antibody strategies to target EphB4 in breast and prostate cancers, with the goal of translating these findings into clinical applications. Her research spans molecular biology, cell signaling, post-translational modifications, and targeted cancer therapies. Dr. Stephenson's research portfolio demonstrates consistent productivity with publications spanning cancer biology, molecular mechanisms, and translational applications. Her work shows a clear progression from fundamental molecular studies toward therapeutic applications, with increasing focus on antibody-based cancer treatments and understanding the complex signaling networks in epithelial cancers. Winner of the Gold Medal at an international medical research technology pitching competition (2025) Winner of QUT Excolo! Pitching competition with $100,000 prize (2023) Fellow of the Higher Education Academy (2019) Vice-Chancellor's Award – "The Extra Mile" (2016) Vice-Chancellor's Performance Award for Student Supervision (2016) Vice-Chancellor's Award for Excellence (finalist) (2014) Vice Chancellor's Performance Award, Teaching (2010) Woman of Distinction in Medical Research Award (2006) Dr. Stephenson has successfully supervised numerous doctoral and master's students through their research degrees, with projects focusing on post-translational modifications of proteins in cancer. Her supervision portfolio includes projects on SUMOylation, UFMylation, and other protein modifications in prostate and breast cancer models. She has received multiple awards recognizing her excellence in student supervision, including the Vice-Chancellor's Performance Award for Student Supervision in 2016. While specific lab details aren't provided in the available information, Dr. Stephenson's research program appears to operate within the School of Biomedical Sciences at QUT, likely with laboratory facilities supporting molecular and cellular cancer research. Her collaborative approach is evident from her extensive publication record with multiple co-authors across different institutions.

• Oncology and carcinogenesis
• Biochemistry and cell biology
• Receptor tyrosine kinases
• +5 more

Professor Damien Harkin is a Professor in the School of Biomedical Sciences at Queensland University of Technology (QUT), within the Faculty of Health. His roles include academic leadership and research in ocular therapies. He holds honorary positions at the Queensland Eye Institute (since 2005) and Australian Red Cross LifeBlood (since 2020). Education: BSc and PhD (Pathology) from the University of Adelaide (1993), postdoctoral training at Harvard Medical School (1994-1996) and the University of Melbourne (1997). Earned a Master of Tertiary Education (2019) from the University of Melbourne. Research Interests: Focuses on cell/tissue therapies for eye diseases, regenerative medicine, biomaterials, and histological techniques. His work has secured over $3M in research funding and led to 80+ publications. Key areas include corneal endothelial cell therapies, silk fibroin-based implants, and ocular surface reconstruction. Awards: None explicitly listed, but recognized for contributions to academic leadership and digital education transformation. Supervised 7 PhD and 2 Master’s students as principal supervisor. Active in grants, including Australian Competitive Grants for corneal bioengineering and biomaterials. Labs/Teams: Leads projects in biomaterial development for ocular tissues, collaborating with interdisciplinary teams in QUT and external institutions.

• Stem cell therapies
• Regenerative medicine
• Tissue engineering
• +6 more

Associate Professor Constantinos Petsoglou is a faculty member at the University of Sydney's Faculty of Medicine and Health within the Speciality of Clinical Ophthalmology and Eye Health . As Education Lead at Save Sight Institute , he focuses on medical education, ocular surface diseases, and corneal regeneration. His research integrates cellular/molecular approaches and clinical trials to advance treatments for Acanthamoeba keratitis , keratoconus , and corneal transplantation . He collaborates with the NSW Tissue Bank and Focus Eye Centre , emphasizing evidence-based medicine and digital health interventions like the Eye Donor Aust app. His recent publications highlight infectious keratitis epidemiology, novel collagen cross-linking protocols, and stem cell applications in corneal repair. Current projects include investigating riposudil for endothelial regeneration and optimizing bioengineered corneal constructs . Despite no listed scientific awards, his work spans clinical practice , public health , and ophthalmic technology over two decades.

• Ophthalmology
• Surgery
• Medical Education
• +2 more